Tower Research Capital LLC (TRC) - BELLEROPHON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,840
-42.4%
7,135
-0.2%
0.00%
Q2 2023$4,934
+123250.0%
7,150
+1371.2%
0.00%
Q1 2023$4
-20.0%
486
-91.7%
0.00%
Q4 2022$5
-99.9%
5,872
-22.3%
0.00%
Q3 2022$8,000
-38.5%
7,561
-28.8%
0.00%
Q2 2022$13,000
+225.0%
10,625
+574.2%
0.00%
Q1 2022$4,000
+100.0%
1,576
+125.8%
0.00%
Q4 2021$2,000
-81.8%
698
-67.2%
0.00%
Q1 2021$11,000
+10.0%
2,131
+47.8%
0.00%
Q4 2020$10,000
-72.2%
1,442
-59.4%
0.00%
Q3 2020$36,000
+1700.0%
3,552
+1977.2%
0.00%
Q2 2020$2,0001710.00%
Other shareholders

There were no reported owners of BELLEROPHON THERAPEUTICS INC in Q4 2023.

NameSharesValueWeighting ↓
View complete list of BELLEROPHON THERAPEUTICS INC shareholders